Portal vein thrombosis and associated factors among patients admitted to Tibebe Ghion hospital, Bahir Dar, Ethiopia: a cross-sectional study, 2021–2024

This study found a notably high prevalence of portal vein thrombosis (15.7%) among hospitalized patients, while chronic liver disease, hepatocellular carcinoma, and elevated platelets significantly increasing risk. These findings underscore the need for heightened clinical vigilance and targeted screening in high-risk populations. Future research should focus on elucidating underlying causal mechanisms, including potential thrombophilic conditions, and should incorporate more diverse and representative patient cohorts to inform comprehensive preventive and therapeutic strategies.